Mike is the CEO and co-founder of Oxford Endovascular Ltd, a spinout from Oxford University.
The company is developing a revolutionary medical device for patients suffering from brain aneurysms; a life-threatening disease affecting 1 in 50 persons in a strongly growing market valued over $1 billion . In 2017 it won ‘Best Med-Tech Start-Up’ at the Oxford Bio Network awards, 1st place at the BioTrinity ‘Perfect Pitch’ competition and an award at the ‘European Health Catapult’ finals.
Mike has 27 years growing international businesses in large corporations & start-ups.
Experienced in strategic planning, execution, team building, gaining regulatory approvals & fund raising.
Mike mentors students and presents at industry conferences. He studied Pre-Clinical Medicine, Physiology & Pharmacology at Southampton University and an MBA from Henley Business School.
12:00 - 13:15
Inward Investment Global Growth – Opportunities and Challenges: China
Sponsored by Penningtons Manches Cooper and James Cowper Kreston
In this session we will hear from investors from China about why technology developed in Oxfordshire is attracting interest and investment from China. We will also hear from Oxfordshire companies who have explored commercial opportunities in China who want to share their experiences with those considering a similar path.
Panellists: Mike Karim – Oxford Endovascular, Qing Lin – James Cowper Kreston, Mark Preston – TECHEETAH Formula E Team and Kegang Wu – BCC LinkToChina
Chaired by Russ Shaw – Global Tech Advocates
Director, Clusters and Harwell Campus Business Development, UKRI-STFC
Co-founder and Chief Scientific Offer, Oxford PV
Managing Director, Ricardo Energy & Environment
Managing Director, Oxford Instruments NanoScience